Evolutionary Genomics, Inc. (FNAM)
- Previous Close
0.4500 - Open
0.4500 - Bid --
- Ask --
- Day's Range
0.4500 - 0.4500 - 52 Week Range
0.4500 - 0.7000 - Volume
300 - Avg. Volume
0 - Market Cap (intraday)
2.995M - Beta (5Y Monthly) -0.36
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3500 - Earnings Date Apr 25, 2024 - Apr 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
www.evolgen.comRelated News
Performance Overview: FNAM
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FNAM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FNAM
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-8.05
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-47.63%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.25M
Diluted EPS (ttm)
-0.3500
Balance Sheet and Cash Flow
Total Cash (mrq)
577.07k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
35.08k
Company Insights: FNAM
FNAM does not have Company Insights